REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Kirsten Williams, MD
Emory University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory University
Atlanta, Georgia, United States
Kirsten M Williams, MDRecruiting - University of Michigan
Ann Arbor, Michigan, United States
Gregory A Yanick, MDRecruiting - University Hospital of Cleveland Uh Seidman Cancer Center
Cleveland, Ohio, United States
Leland Metheny, MDNot, yet, recruiting - University of Oklahoma Health Sciences Center, Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Jennifer Holter, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Oct 2020
- Primary completion
- 14 Dec 2026
- Completion
- 30 Nov 2027
- Last update posted
- 18 Aug 2026
- Registered enrollment
- 50
- Registry id
- NCT03541889
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.